Stock Information
Natera Inc (NTRA)
Ticker Symbol: NTRA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $30,025.77 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.6379
Revenue (TTM): $17.67 M
Dividend Yield: N/A%
ROE: -15.13%
Latest News
-
Guggenheim Maintains Buy on Natera, Raises Price Target to $290
Mon, Jun 29, 2026 10:03 AM
-
Natera Partners With Aveta On Late-Stage Head And Neck Cancer Trial
Mon, Jun 29, 2026 6:12 AM
-
Natera: All-Time Share Price High A Potential Caveat For Investors, Despite Promise
Fri, Jun 26, 2026 4:03 PM
-
The Disinflation Trade Has A New Address: Genomics
Fri, Jun 26, 2026 2:20 PM
-
CORRECTION: Bernstein Reinstates Outperform on Natera, Announces $310 Price Target
Fri, Jun 26, 2026 9:53 AM
-
Natera Partners With Eledon Pharmaceuticals To Incorporate Its Prospera Kidney Transplant Assessment Test Into Eledon’s Planned Phase 3 Clinical Trial Of Tegoprubart, An Investigational Therapy Designed To Prevent Organ Rejection In Kidney Transplantation
Thu, Jun 25, 2026 7:08 AM
-
Natera Secures Landmark Japan Nod For Signatera In Colorectal Cancer
Wed, Jun 24, 2026 2:14 PM
-
BTIG Maintains Buy on Natera, Raises Price Target to $275
Wed, Jun 24, 2026 1:29 PM
-
Barclays Maintains Overweight on Natera, Lowers Price Target to $260
Wed, Jun 24, 2026 10:43 AM
Key Financials
Financial data not available
